Crossmark

Time to Approval of Drugs in FDA Expedited Programs, 2020–2024

Crossref DOI link: https://doi.org/10.1007/s12247-026-10762-0

Published Online: 2026-06-11

Published Print: 2026-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Damour, Nicole

Schultz, Thomas https://orcid.org/0000-0001-7524-6011
Abou-Gharbia, Magid

Lebo, David https://orcid.org/0000-0001-5465-1376
License Information

Text and Data Mining valid from 2026-06-11

Version of Record valid from 2026-06-11
More Information

Article History

Received: 27 February 2026

Accepted: 10 May 2026

First Online: 11 June 2026

Declarations

:

: The authors declare no competing interests.